| Literature DB >> 27313577 |
Klaus Ley1, Akula Bala Pramod2, Michael Croft3, Kodi S Ravichandran4, Jenny P Ting5.
Abstract
Macrophages are central to both innate and adaptive immunity. With few exceptions, macrophages are the first cells that sense trouble and respond to disturbances in almost all tissues and organs. They sense their environment, inhibit or kill pathogens, take up apoptotic and necrotic cells, heal tissue damage, and present antigens to T cells. Although the origins (yolk sac versus monocyte-derived) and phenotypes (functions, gene expression profiles, surface markers) of macrophages vary between tissues, they have many receptors in common that are specific to one or a few molecular species. Here, we review the expression and function of almost 200 key macrophage receptors that help the macrophages sense what is going on, including pathogen-derived molecules, the state of the surrounding tissue cells, apoptotic and necrotic cell death, antibodies and immune complexes, altered self molecules, extracellular matrix components, and cytokines, including chemokines.Entities:
Keywords: defense; immunity; inflammation; macrophages; pathogens
Year: 2016 PMID: 27313577 PMCID: PMC4890338 DOI: 10.3389/fimmu.2016.00204
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Figure 1Gene expression in resident tissue-specific macrophages (microglia, lung, liver, spleen, intestinal, adipose) and bone marrow-derived macrophages (BMDM) for comparison. Heat maps based on hierarchical clustering results from microarray and RNA-Seq data for (A) apoptosis receptors, (B) complement receptors, (C) toll-like receptors, (D) NOD-like receptors, (E) RNA and DNA sensors, (F) C-type lectins, (G) scavenger receptors, (H) integrins, (I) tumor necrosis factor receptor superfamily, (J) Fc receptors, (K) G-protein-coupled receptors, and (L) cytokine receptors. Gene expression levels are expressed in log2 values, differences shown in color scale after Z-score transformation. Colors scale bar ranges from red (+3) to green (−3). Light gray indicates undetectable.
PtdSer recognition receptors.
| Gene name | PtdSer receptors | Function | PtdSer binding |
|---|---|---|---|
| BAI1 | Upstream of ELMO1-DOCK180-RAC, engulfment | Direct PtdSer binding | |
| TIM1 | Also hepatitis A virus receptor | Direct PtdSer binding by metal ion-dependent binding site | |
| TIM3 | Also for antigen cross-presentation | ||
| TIM4 | Only tethering of apoptotic cells without direct signaling to engulfment | ||
| Tyro3 | Tyrosine kinase receptor | Indirect PtdSer binding through Gas6 or protein S | |
| Axl | Tyrosine kinase receptor | ||
| Mer | Tyrosine kinase receptor, universal mouse macrophage marker |
Complement receptors.
| Gene name | Complement receptors | CD name | Function |
|---|---|---|---|
| CR1 | CD35 | Binds C3b and C4b, processes opsonized particles | |
| CR2 | CD21 | Binds C3bi, C3d. In the mouse, both CR1 and CR2 are derived from the | |
| CR3 | CD11b/CD18 | Obligatory heterodimer, binds C3bi, denatured proteins (and many other ligands) | |
| CR4 | CD11c/CD18 | Obligatory heterodimer, binds C3bi, denatured proteins | |
| C3aR | Binds C3a | ||
| C5aR1 | CD88 | Binds C5a, activates macrophages | |
| C5aR2 | Binds C3a, C5a, and their desarginated inactive forms | ||
| CD59 | CD59 | Inhibits the membrane attack complex | |
| MCP | CD46 | CD46 and CD55 inactivate the C3/C5 cleaving enzymes | |
| Decay-accelerating factor DAF | CD55 |
Toll-like receptors.
| Gene name | TLR | Ligands | Location and function | Dimerization |
|---|---|---|---|---|
| TLR1 | Bacterial lipoproteins | Cell surface. Activates NFkB through TIRAP, MyD88, IRAKs, TRAF6 | Heterodimerizes with TLR2 | |
| TLR2 | Lipoproteins, LTA, PGN, lipoarabinomannan, viral proteins, fungal mannans, trypanosome tGPI–mutin | Cell surface. Activates NFkB through TIRAP, MyD88, IRAKs, and TRAF6 | Heterodimerizes with TLR1 or 6 or CD36, homodimer in endosomes | |
| TLR3 | Viral RNA | Intracellular vesicles, activates NFkB through TRIF-TAK1 and type I interferons through TRIF-TRAF3 | Homodimer in endosomes | |
| TLR4 | LPS, fungal mannans, glycoinositol-phospholipids of parasites, oxLDL | Cell surface and phagosomes, activates NFkB through TIRAP, MyD88, IRAKs, and TRAF6, and induces type 1 interferons through TRAM-TRIF-IRF3 | Homodimer | |
| TLR5 | Flagellin | Cell surface. Activates NFkB through MyD88, IRAKs, TRAF6 | Homodimer | |
| TLR6 | TLR2/6: bacterial lipoproteins, fungal zymosan, β-glucan | Cell surface. Activates NFkB through TIRAP, MyD88, IRAKs, TRAF6 | Heterodimerizes with TLR2 | |
| TLR7 | Bacterial, viral, and fungal RNA | Intracellular vesicles, activates NFkB through MyD88, TRAF6, induces type I interferons via MyD88 | Homodimer in endosomes | |
| TLR8 | Viral RNA | Intracellular vesicles | ||
| TLR9 | Bacterial, viral, fungal, and parasite DNA | Intracellular vesicles, activates NFkB through MyD88, TRAF6, induces type I interferons via MyD88 | Homodimer in endosomes |
NOD-like receptors.
| Gene name | NLR | Pathogen or disturbance | Downstream effectors, function, and regulation |
|---|---|---|---|
| NLRP3 | Cellular stress | Activates caspase-1 through ASC | |
| ER stress | |||
| And ATP | Inhibited by NO from iNOS (S-nitrosylation) | ||
| Monosodium urate, alum | |||
| NLRC4 | Bacterial type III (T3SS) and IV (T4SS) secretion system, cytosolic flagellin | Activates caspase-1 to activate IL-1 and IL-18, blocks STING pathway | |
| NLRC3 | HSV | Blocks STING pathway | |
| NLRP1A | Lethal toxin (LT) of | ||
| NLRP1B | Muramyl dipeptide (MDP) and titanium dioxide (human) | ||
| NLRP1C | |||
| NLRP6 [PYPAF5] | Pathobiont bacteria, Bacteroidetes (Prevotellaceae), and TM7 microbiota | Blocks NFkB and MAPK pathway, activates caspase-1, inflammasome | |
| NLRP7 | Mycoplasma acylated lipopeptide (acLP) | Inflammasome: hydatidiform | |
| NLRP12 | Inflammasome function, inhibits NFkB and MAPK | ||
| NLRC5 | Bacteria, PAMPs, DAMPs, rhinovirus | Inflammasome function | |
| MHC class I gene expression | |||
| AIM2 | Cytosolic DNA | Activates Caspase-1 through ASC | |
| ASC | Common adaptor for inflammasome activation | Activates caspase-8 and -9 | |
| NAIP1 | NAIPs provide ligand specificity to the NLRC4 inflammasome. | Naip1, 2, 5, and 6 provide ligand specificity to the NLRC4 inflammasome. Specifically, Naip1 detects the bacterial rod, and Naip5 and 6 detect bacterial flagellins ( | |
| NAIP2 | |||
| NAIP4 | |||
| NAIP6 |
C-type lectins.
| Gene name | C-type lectin | CD | Binds ligands from | Function |
|---|---|---|---|---|
| DEC-205 | CD205 | HIV, | Uptake of pathogens and apoptotic cells | |
| Mgl1 | CD301a | Streptococci, Lactobacilli, apoptotic cells: Sialoadhesin | Uptake of pathogens and apoptotic cells | |
| DNGR-1 | F-actin | Uptake of necrotic cells | ||
| Mincle | α-mannose and glycolipids from | Necrotic cell uptake; couples through FcRγ, activates NFkB | ||
| BGR | CD369 | Beta-1,3-linked and beta-1,6-linked glucans from fungi and plants | ||
| DCIR4 | Unknown | |||
| MICL | CD371 | Down regulated by cell activation | ||
| Dectin-2-like | ||||
| DCAR | Associates with Fc receptor γ chain | |||
| MCL, MPCL | CD368 | Endocytotic, signals through Syk | ||
| DCIR3 | ||||
| DCIR2 | Bisecting | |||
| Langerin | CD207 | Measles virus | ||
| DC-SIGN | CD209 | Microbial polysaccharides, sialylated antibody | Possible role in Th17 response | |
| SIGNR1, CLEC4m | CD209b | Oligomannose | Interacts with C1q | |
| SIGNR3 | CD209d | |||
| Clec2 | High on platelets | Required for lymphangiogenesis, separates lymphatics from blood vessels | ||
| L-selectin | CD62L | High endothelial venules, PSGL-1 | Rolling of Ly6Chi monocytes | |
| P-selectin | CD62P | PSGL-1, TIM1 | Endothelial cells: rolling; macrophages: unknown | |
| E-selectin | CD62E | PSGL-1, CD44, CD43, others | Largely restricted to endothelium |
Scavenger receptors.
| Gene name | Systematic name | Other names | Ligands and function |
|---|---|---|---|
| SR-A1 | SCARA1 | Heat shock proteins, acLDL, oxLDL | |
| SR-A3 | SCARA3 | Protection from ROS | |
| SR-A4 | SCARA4 | Modified LDL | |
| SR-A5 | SCARA5 | Binds bacteria | |
| SR-A6 | MARCO | Bacterial clearance from lung and blood | |
| SR-B1 | SCARB1 | HDL | |
| SR-B2 | CD36 | Thrombospondin [modulates angiogenesis], foam cell formation in atherosclerosis by uptake of oxLDL, binds fungi, bacteria, | |
| SR-B3 | LIMP2 | Delivers β-glucocerebrosidase from the endoplasmic reticulum to lysosomes, enterovirus 71 (EV71), coxsackievirus 7 (CVA7), CVA14, CVA16 | |
| SR-D1 | Macrosialin | Controversial: may bind oxidized lipoproteins, apoptotic cells, but inconsistent data | |
| SR-E1 | LOX-1 | oxLDL, CRP | |
| SR-E2 | Dectin-1 | Bacterial, fungal, and plant carbohydrates β-glucans interacts with TLR2 | |
| SR-F1 | SCARF1 | Calreticulin, fungal and heat shock proteins, cross-presentation of antigens on MHC-I. Binds oxLDL. Apoptotic cell clearance | |
| SR-F2 | SREC-II | ||
| SR-F3 | MEGF10 | Amyloid-β | |
| SR-G1 | RS-PSOX | oxLDL, phagocytosis of bacteria, chemotaxis through CXCR6 | |
| SR-H1 | Stabilin-1 | Lymphocyte adhesion, transmigration, angiogenesis, apoptotic cell clearance, and intracellular trafficking | |
| SR-H2 | Stabilin-2 | Binds PS, interacts with GULP and thymosin-β4 to initiate uptake of apoptotic cells | |
| SR-I1 | CD163 | Hemoglobin-haptoglobin, anti-inflammatory signaling, secretion of cytokines IL-6 and IL-10 | |
| SR-J1 | RAGE | Advanced glycation end products, high mobility group protein box 1, S-100, oxidative stress, pro-inflammatory | |
| Galectin-3 binding protein | GAL3BP | Binds galectin-1 and 3, anti-inflammatory, produced by M1 macrophages |
Cytokine receptors on macrophages.
| Gene name | Common name | CD | Ligands and function |
|---|---|---|---|
| IFN-γ R | IFN-γ: forces M1 polarization | ||
| IL-1 R1 | CD121a | IL-1α and β, pro-inflammatory | |
| IL-1 R2 | CD121b | IL-1α and β, pro-inflammatory | |
| IL-4 R | CD124 | IL-4: forces M2 polarization | |
| IL-5 R | CD125 | IL-5: forces M2 polarization | |
| IL-10Rα | CD210 | IL-10: strongly anti-inflammatory, suppresses antigen presentation ( | |
| IL-13 R | CD213a | IL-13: forces M2 polarization | |
| IL-13 R | CD213b | IL-13: forces M2 polarization | |
| IL-17RA | CD217 | IL-17a: activates macrophages | |
| IL-17RB | Basophil function, asthma | ||
| IL-17RC | Needed for IL-17A-induced CXC chemokine expression | ||
| IL-17RD | Anti-inflammatory | ||
| IL-17RE | Receptor for IL-17C: immunity to intestinal pathogens | ||
| IL-27R | IL-27: regulates Th1 and Treg | ||
| TGF-βR1 | TGF-β: inactivates macrophages, determining receptor of microglia | ||
| TGF-βR2 | TGF-β: inactivates macrophages | ||
| TGF-βR3 | TGF-β: inactivates macrophages |
TNF receptor superfamily.
| Gene name | Systematic name | Other names | Ligands and function |
|---|---|---|---|
| Tnfrsf1a | TNFR1 | TNF, soluble lymphotoxin α: pro- and anti-inflammatory (apoptosis) many cell types | |
| Tnfrsf1b | TNFR2 | TNF, soluble lymphotoxin α: pro-inflammatory many cells; T cell activation | |
| Tnfrsf3 | LTβR | Membrane lymphotoxin β and LIGHT: pro-inflammatory for APC and tissue cells; lymph node development | |
| Tnfrsf4 | OX40, CD134 | OX40L (=CD252): T and NK activation/differentiation | |
| Tnfrsf5 | CD40 | CD40L (=CD154): immunoglobulin class switching, APC activation | |
| Tnfrsf6 | Fas | FasL (=CD178): apoptosis/cell death | |
| Tnfrsf7 | CD27 | CD70: T and B cell activation; antibody production | |
| Tnfrsf8 | CD30 | CD30L (=CD153): T and B cell activation | |
| Tnfrsf9 | 4-1BB, CD137 | 4-1BBL: T and NK activation/differentiation | |
| Tnfrsf10b | TRAIL R2 | TRAIL (=CD253): apoptosis in tumor cells and T cells | |
| Tnfrsf11a | RANK | RANKL (=CD254): osteoclast and lymph node development; activation of APC. Blockers of RANKL (antibody: denosumab) binding to RANK are used clinically to treat osteoporosis | |
| Tnfrsf11b | OPG | Decoy receptor for RANK: modulates osteoclastogenesis | |
| Tnfrsf12a | Fn14 | TWEAK: tissue inflammation | |
| Tnfrsf13b | TACI, CD267 | APRIL (= CD256) and BAFF (= CD257): B cell activation/differentiation | |
| Tnfrsf13c | BAFFR | BAFF (= CD257): B cell differentiation/survival. Blockers of BAFF (antibody: belimumab) binding to its receptors BAFFR, TACI, and BCMA are used clinically to treat systemic lupus. | |
| Tnfrsf14 | HVEM | LIGHT (= CD258): T cell activation; pro-inflammatory tissue cells and APC; BTLA: T cell inhibition | |
| Tnfrsf17 | BCMA | APRIL (= CD256) and BAFF (= CD257): B cell activation/differentiation | |
| Tnfrsf18 | GITR | GITRL: T and B cell activation | |
| Tnfrsf19 | TROY | Nogo coreceptor: axon regeneration? | |
| Tnfrsf21 | DR6 | Amyloid precursor protein: neuron death? | |
| Tnfrsf22 and 23 | mDcTRAIL R2 and mDcTRAILR1 | Decoy receptors for TRAIL only expressed in mice: neutralize TRAIL activity | |
| Tnfrsf25 | DR3 | TL1A: T cell activation/differentiation | |
| Tnfrsf27 | XEDAR | EDA: control of hair follicle, sweat gland, teeth development |
Fc receptors.
| Gene name | FcR | CD | Function |
|---|---|---|---|
| Fcgr1 | FcRγI | CD64 | High affinity IgG binding |
| Fcgr2b | FcRγIIb | CD32 | Low affinity IgG R, immune complexes |
| Fcgr3 | FcRγIII | CD16 | Low affinity IgG R, immune complexes |
| Fcgr4 | FcRγIII-2 | CD16-2 | Low affinity IgG R, immune complexes |
| Fcer1a | FceR | High affinity IgE receptor | |
| Fcer1g | Fc γ chain | CD23 | Adaptor for most Fc receptors |
| Fcer2a | FcreR2 | CD23a | Low affinity IgE receptor |
| Ms4a2 | Fcer1b |
GPCRs expressed on macrophages.
| Gene name | GPCR | CD, other | Function |
|---|---|---|---|
| CCR1 | CD191 | Pro-inflammatory | |
| CCR2 | CD192 | Recruits monocytes | |
| CCR5 | CD195 | Arrest, integrin activation, recruits monocytes | |
| CCR7 | CD197 | Directs macrophages and dendritic cells to lymphatics and lymph nodes, also involved in lymphocyte homing and development | |
| CX3CR1 | Fractalkine R: Macrophage survival | ||
| Adenosine A1 | Pro-inflammatory, sleep-inducing | ||
| Adenosine A2a | Anti-inflammatory. Istradefylline is an A2A antagonist approved for Parkinson’s disease | ||
| Adenosine A2b | Pro-inflammatory | ||
| Adenosine A3 | |||
| ATP R 1 | ATP and ADP receptor | ||
| ATP R 2 | Apoptotic cell recognition | ||
| ATP R 12 | ATP and ADP receptor | ||
| S1P1 | CD363 | Regulates lymphocyte trafficking | |
| S1P2 | EDG5 | ||
| S1P3 | EDG3 | ||
| S1P4 | EDG6 |
Integrins.
| Gene Name | Integrin | CD, other | Function |
|---|---|---|---|
| β1 integrins | CD29 | Pairs with α1–11 | |
| α1β1 | CD49a | Collagen receptor | |
| α3β1 | CD49c | Type 4 collagen receptor | |
| α4β1 | CD49d | Binds VCAM-1 and alternatively spliced fibronectin | |
| VLA-4 | |||
| α5β1 | CD49e | Bind fibronectin, pro-inflammatory signal | |
| VLA-5 | |||
| α6β1 | CD49f | Laminin binding | |
| VLA-6 | |||
| α7β1 | Muscle development | ||
| α8β1 | Extracellular matrix assembly? | ||
| α9β1 | Fertilization of egg | ||
| α10β1 | Collagen binding | ||
| α11β1 | Collagen binding | ||
| β2 integrins | CD18 | Pairs with αL, αM, αX, αd | |
| αLβ2 | CD11a/CD18 | Adhesion to ICAM-1, 2, and 3 | |
| αMβ2 | CD11b/CD18 | Binds C3bi, ICAM-1, denatured proteins, and many other ligands | |
| αXβ2 | CD11c/CD18 | Binds C3bi, ICAM-1, denatured proteins | |
| αDβ2 | CD11d/CD18 | Binds ICAM-3 | |
| αIIbβ3 | CD41/CD61 | High on platelets, binds fibrinogen | |
| αVβ3 | CD51/CD61 | Major receptor for vitronectin, uptake of apoptotic cells | |
| αVβ6 | CD51 | Involved in TGFβ activation ( | |
| β7 integrins | Ly69 | Intestinal specific | |
| α4β7 | CD49d | Binds MAdCAM-1 | |
| αEβ7 | CD103 | Binds to E-cadherin |